{
    "id": "85ffdba9-4ecd-4a76-b91b-52eeb3f3acc3",
    "indications": "ztalmy indicated treatment seizures associated cyclin-dependent kinase-like 5 ( cdkl5 ) deficiency disorder ( cdd ) patients 2 years age older .",
    "contraindications": "administer ztalmy orally three times daily food . ( 2.1 ) titrate ztalmy gradually according recommended schedules . full prescribing information . ( 2.1 ) patients weighing 28 kg less ( 2.1 ) : starting 6 mg/kg three times daily ( 18 mg/kg/day ) maximum 21 mg/kg three times daily ( 63 mg/kg/day ) . patients weighing 28 kg ( 2.1 ) : starting 150 mg three times daily ( 450 mg daily ) maximum 600 mg three times daily ( 1800 mg daily ) . patients severe hepatic impairment : full prescribing information recommendation . ( 2.3 )",
    "adverseReactions": "none .",
    "ingredients": [
        {
            "name": "ganaxolone",
            "code": "98WI44OHIQ"
        },
        {
            "name": "anhydrous citric acid",
            "code": "XF417D3PSL"
        },
        {
            "name": "hypromellose, unspecified",
            "code": "3NXW29V3WO"
        },
        {
            "name": "methylparaben",
            "code": "A2I8C7HI9T"
        },
        {
            "name": "polyvinyl alcohol, unspecified",
            "code": "532B59J990"
        },
        {
            "name": "propylparaben",
            "code": "Z8IX2SC1OH"
        },
        {
            "name": "water",
            "code": "059QF0KO0R"
        },
        {
            "name": "sodium benzoate",
            "code": "OJ245FE5EU"
        },
        {
            "name": "sodium citrate, unspecified form",
            "code": "1Q73Q2JULR"
        },
        {
            "name": "sodium lauryl sulfate",
            "code": "368GB5141J"
        },
        {
            "name": "sucralose",
            "code": "96K6UQ3ZD4"
        }
    ],
    "organization": "Immedica Pharma US Inc",
    "name": "ZTALMY",
    "effectiveTime": "20250424",
    "indications_original": "ZTALMY is indicated for the treatment of seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) in patients 2 years of age and older.",
    "contraindications_original": "Administer ZTALMY orally three times daily with food. ( 2.1 ) Titrate ZTALMY gradually according to the recommended schedules. See full prescribing information. ( 2.1 ) Dosage for patients weighing 28 kg or less ( 2.1 ): the starting dosage is 6 mg/kg three times daily (18 mg/kg/day) the maximum dosage is 21 mg/kg three times daily (63 mg/kg/day). Dosage for patients weighing over 28 kg ( 2.1 ): the starting dosage is 150 mg three times daily (450 mg daily) the maximum dosage is 600 mg three times daily (1800 mg daily). Patients with severe hepatic impairment: see full prescribing information for dosage recommendation. ( 2.3 )",
    "adverseReactions_original": "None."
}